JointIQ supplement shows promise for active adults with knee discomfort
NCT ID NCT07382622
First seen Feb 03, 2026 · Last updated May 21, 2026 · Updated 13 times
Summary
This study tested whether a daily capsule of astragaloside (JointIQ) could reduce knee discomfort and improve mobility in healthy adults who exercise regularly. Fifty participants took either the supplement or a placebo for 12 weeks. Researchers measured knee stability, range of motion, and self-reported symptoms to see if the supplement offered any benefit over placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for JOINT DISCOMFORT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chung Shan Medical University
Taichung, 402, Taiwan
Conditions
Explore the condition pages connected to this study.